This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
October 22, 2018
Göran Wessman resigns from the Board – joins the Nomination Committee now appointed in Vicore Pharma Holding
October 22, 2018
BioClin Therapeutics to Participate in BTIG Biotech Conference
October 22, 2018
BONESUPPORT starts selling CERAMENT® BONE VOID FILLER Direct in the US via its own New Distributor Network
October 18, 2018
GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
October 17, 2018
Nordic Nanovector ASA: Change of Date for Q3 2018 Results Presentation and Webcast
October 15, 2018
Nomination Committee appointed in respect of AGM 2019 in Oncopeptides
October 15, 2018
Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer
October 12, 2018
GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology
October 12, 2018
Oncopeptides to present at the Jefferies London Healthcare Conference on November 14th
October 12, 2018
Nordic Nanovector Presentations at the Annual Congress of the European Association of Nuclear Medicine (EANM)